| June 12, 2015 | ISSUE NUMBER 404 VOL 4 |
Top Story
Pharm Exec's Top 50 Pharma Companies
Our annual Pharma 50 listing is clear proof that once-small and midsize biopharma companies are moving up to join the top ranks of big Pharma. Specialty drug sales, record-breaking M&A paired with tax synergies, and global expansion helped to bring a new face into this year's Pharma 50 top 10, and substantially boosted the rankings of several others
...Read more
Worldwide Clinical Trials
Scientifically Minded, Medically Driven
You work tirelessly to bring better products to market and improve patients' lives. At WCT, we support you by consistently delivering quality results, on-time, on-budget and always bolstered
by unrivaled science and medicine. Flexible. Reliable. Committed.
 We aren't satisfied until you are.
Join us at DIA, Booth #1311!
Analysis
Latest Pharma M&A and Financial Trends: Frenzy and Risks Escalate
The pharma industry is making progress and going through a frenzy of activity on the strategic, business, M&A and financial fronts, writes Peter Young
...Read more
On the road to integration
Moving your multichannel program into the fast lane
Live webcast: Wednesday, 1 July 2015 at 11 am EDT | 16:00 BST | 17:00 CEST
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually “make it happen” for your product.
 Register for free
Regulatory
States Face Harsh Reality of Obamacare
For the 17 states that set up their own state exchanges under Obamacare, finding ways to manage a couple aspects of the new law are turning 2015 into a “Year of Harsh Realities.” Tom Norton explains why
...Read more
Breaking through the complexity
Improving oncology treatment and access in the UK
Live webcast: 30 June 2015 at 9 am EDT | 14:00 BST | 15:00 CEST
Join Dean Summerfield, Senior Vice President, Commercial and Consulting from Quintiles and Dr Jason Lester, Consultant Clinical Oncologist at the Velindre Cancer Centre as they discuss improving innovative oncology treatment and access in the UK
 Register for free
Regulatory
Drug Contamination Problems Hit NIH
Serious drug quality issues have forced the National Institutes of Health (NIH) to shutter its in-house facility for producing clinical supplies for certain clinical trials, a development that starkly illustrates the complexity of manufacturing sterile products to meet good manufacturing standards, writes Jill Wechsler
...Read more
Patient adherence in Germany - benefit vs. cost-containment
Live webcast: Wednesday, 24 June 2015 at 11 am EDT | 16:00 BST | 17:00 CEST
Join Joanne Thiele, Market Access Project Manager from Quintiles Germany and Hans Holger Bleß, Director of Health Services Research department at IGES Institut GmbH as they discuss the importance of patient adherence programs in Germany.
 Register for free
Deals
Hard Science, High Hopes: Pharm Exec's Dealmakers' Roundtable
Masters of the deal converged in New York to discuss the status of their trade and the forces propelling M&A, licensing, and partnerships in the life sciences for 2015
...Read more
|
|
|
 //Medgenics (Philadelphia, PA) announced the appointment of Barbara Duncan to the company's Board of Directors effective July 22. //AMAG Pharmaceuticals (Waltham, MA) named Aaron Pelta as Vice President of Business Development and Transactions.
//Allied Minds (Boston, MA) appointed Kevin Sharer, former Chairman and CEO of Amgen, to its Board of Directors. //Amyris (Emeryville, CA) appointed Caroline Hadfield as Senior Vice President, Personal Care, effective June 15, and Cynthia (“Cindy”) Bryant as Senior Vice President Corporate Development & Collaborations, effective June 22, 2015. //Kantar Health (New York, NY) promoted Jade Cusick to a global role as Chief Client Officer. // |
|
|
|
|
|
